AI assistant
Sending…
DAVITA INC. — Director's Dealing 2016
May 25, 2016
30643_dirs_2016-05-24_660f436b-d846-45c8-9aa2-00b551f4a055.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-05-20
Reporting Person: THIRY KENT J (Director, Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-20 | Common Stock | S | 32880 | $76.9945 | Disposed | 39184 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 458994 | Indirect |
Footnotes
F1: Represents the weighted average sale price of $76.9945. The range of prices for the sale of these shares was $76.99-$77.01, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25